GlassScriptPhysician profile
Michael P Obrien
NPI 1528037710
$3,226.53
in general payments reported to CMS, 2019-2025
10 companies · $266 in 2025
The $266 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $938 · 2020: $63.03 · 2021: $156 · 2022: $151 · 2024: $1,653 · 2025: $266.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,260 · Food and Beverage: $658.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,260.32 |
| Food and Beverage | $658.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Linvatec Corporation | $1,527.74 | 2024 | Hall Power, Biobrace 23mm, Linvatec Arthroscopy |
| Stryker Corporation | $771.01 | 2019-2025 | Flexible Guide Pin (Stryker Acl Versitomic) |
| Smith+Nephew, INC. | $629.58 | 2019-2025 | Stravix Pl, Stravix, Stravix Mesh |
| Acumed LLC | $154.48 | 2025 | Acumed |
| Amgen INC. | $55.19 | 2019-2025 | Prolia, Evenity |
| Pacira Therapeutics, INC. | $26.77 | 2019 | |
| Abbott Laboratories | $17.31 | 2024 | Eterna |
| Paratek Pharmaceuticals, INC. | $15.34 | 2022 | |
| Smoky Mountain Surgical LLC | $14.70 | 2024 | |
| Sanofi-Aventis U.S. LLC | $14.41 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Obrien listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.